The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study

Sarah K. Brode; Hannah Chung; Michael A. Campitelli; Jeffrey C. Kwong; Rinku Sutradhar; Alex Marchand-Austin; Kevin L. Winthrop; Frances B. Jamieson; Theodore K. Marras

doi:10.1183/13993003.01875-2019

The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study

Sarah K. Brode, Hannah Chung, Michael A. Campitelli, Jeffrey C. Kwong, Rinku Sutradhar, Alex Marchand-Austin, Kevin L. Winthrop, Frances B. Jamieson, Theodore K. Marras

School Of Public Health

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Article number	1901875
Journal	European Respiratory Journal
Volume	56
Issue number	3
DOIs	https://doi.org/10.1183/13993003.01875-2019
State	Published - Sep 1 2020

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1183/13993003.01875-2019

Cite this

Brode, S. K., Chung, H., Campitelli, M. A., Kwong, J. C., Sutradhar, R., Marchand-Austin, A., Winthrop, K. L., Jamieson, F. B., & Marras, T. K. (2020). The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study. European Respiratory Journal, 56(3), Article 1901875. https://doi.org/10.1183/13993003.01875-2019

Brode, SK, Chung, H, Campitelli, MA, Kwong, JC, Sutradhar, R, Marchand-Austin, A, Winthrop, KL, Jamieson, FB & Marras, TK 2020, 'The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study', European Respiratory Journal, vol. 56, no. 3, 1901875. https://doi.org/10.1183/13993003.01875-2019

@article{ac68833843044d138be255b5fb4d4123,

title = "The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study",

author = "Brode, {Sarah K.} and Hannah Chung and Campitelli, {Michael A.} and Kwong, {Jeffrey C.} and Rinku Sutradhar and Alex Marchand-Austin and Winthrop, {Kevin L.} and Jamieson, {Frances B.} and Marras, {Theodore K.}",

note = "Funding Information: Conflict of interest: S.K. Brode reports grants from Insmed Pharmaceuticals and Canadian Institutes of Health Research (CIHR), personal fees for educational activities from Boehringer Ingelheim and AstraZeneca, outside the submitted work. H. Chung has nothing to disclose. M.A. Campitelli has nothing to disclose. J.C. Kwong has nothing to disclose. R. Sutradhar has nothing to disclose. A. Marchand-Austin has nothing to disclose. K.L. Winthrop reports grants and personal fees from Insmed, personal fees from Johnson & Johnson, Paratek, Red Hill Biopharma and Horizon, outside the submitted work. F.B. Jamieson has nothing to disclose. T.K. Marras reports grants and personal fees for consultancy from Insmed, personal fees for educational activities from AstraZeneca, France Foundation and Novartis, personal fees for consultancy from Horizon and RedHill, outside the submitted work.",

year = "2020",

month = sep,

day = "1",

doi = "10.1183/13993003.01875-2019",

language = "English (US)",

volume = "56",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "3",

}

TY - JOUR

T1 - The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease

T2 - a population-based cohort study

AU - Brode, Sarah K.

AU - Chung, Hannah

AU - Campitelli, Michael A.

AU - Kwong, Jeffrey C.

AU - Sutradhar, Rinku

AU - Marchand-Austin, Alex

AU - Winthrop, Kevin L.

AU - Jamieson, Frances B.

AU - Marras, Theodore K.

N1 - Funding Information: Conflict of interest: S.K. Brode reports grants from Insmed Pharmaceuticals and Canadian Institutes of Health Research (CIHR), personal fees for educational activities from Boehringer Ingelheim and AstraZeneca, outside the submitted work. H. Chung has nothing to disclose. M.A. Campitelli has nothing to disclose. J.C. Kwong has nothing to disclose. R. Sutradhar has nothing to disclose. A. Marchand-Austin has nothing to disclose. K.L. Winthrop reports grants and personal fees from Insmed, personal fees from Johnson & Johnson, Paratek, Red Hill Biopharma and Horizon, outside the submitted work. F.B. Jamieson has nothing to disclose. T.K. Marras reports grants and personal fees for consultancy from Insmed, personal fees for educational activities from AstraZeneca, France Foundation and Novartis, personal fees for consultancy from Horizon and RedHill, outside the submitted work.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85090816285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090816285&partnerID=8YFLogxK

U2 - 10.1183/13993003.01875-2019

DO - 10.1183/13993003.01875-2019

M3 - Letter

C2 - 32409574

AN - SCOPUS:85090816285

SN - 0903-1936

VL - 56

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 3

M1 - 1901875

ER -

The impact of different antibiotic treatment regimens on mortality in Mycobacterium avium complex pulmonary disease: a population-based cohort study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this